[{"from": "human", "value": "Please give me some details about this molecule. [C][N][Branch1][C][C][C][=Branch1][C][=O][C@@H1][C@H1][Branch2][Ring2][#C][C@][Branch2][Ring1][#C][C@@][Branch1][Branch1][C@@H1][Ring1][Branch1][O][Branch2][Ring1][Ring2][C][=C][Branch1][Ring2][O][Ring1][#Branch1][C][=C][Branch1][#Branch1][C][=C][Ring1][#Branch1][O][C][O][C][O][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][C][=C][C][=C][C][=C][Ring1][=Branch1]"}, {"from": "gpt", "value": "The molecule is the eponymous member of a class of anti-cancer phytochemicals known as rocaglamides. Rocaglamides are secondary metabolites of the plant genus Aglaia, and extracts of the plant have traditionally been used as a form of insect repellant due to its natural insecticidal properties. Reports of Aglaia anti-tumor activity date back as far as 1973, and rocaglamide-A was first isolated in 1982 from the species A. elliptifolia. Rocaglamide and a number of its derivatives (e.g. [didesmethylrocaglamide]) are currently being studied for use as chemotherapeutic agents in the treatment of various leukemias, lymphomas, and carcinomas, as well as adjuvant therapy in the treatment of certain chemotherapy-resistant cancers."}]